Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oral rehydration therapy (ORT), also known as oral rehydration solution (ORS), is a medical treatment used to prevent and treat dehydration, especially that caused by diarrhea. The therapy involves drinking a precise mixture of water, glucose (or sucrose), and electrolytes—primarily sodium chloride, potassium chloride, and sodium citrate or bicarbonate. The mechanism of action relies on the sodium-glucose cotransport system in the small intestine; glucose enhances the absorption of sodium and thus water into the bloodstream. Potassium helps replace losses from diarrhea or vomiting and prevents hypokalemia; citrate corrects metabolic acidosis associated with dehydration[1][2][3][5][6][8]. ORT is recommended by major health organizations such as WHO and UNICEF for all ages with mild to moderate dehydration due to diarrheal illness. It has dramatically reduced global childhood mortality from diarrheal diseases since its adoption in the 1970s[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oral rehydration therapy.